Dra. Maite Huarte
After completing her PhD at the National Center for Biotechnology (CSIC) in Universidad Autónoma de Madrid, Huarte’s postdoctoral work was carried at Harvard Medical School on chromatin regulation, and at the Broad Institute of Harvard and MIT, where she participated in pioneering lncRNA studies.
Since 2011 Dr. Huarte leads a research group at CIMA (University of Navarra). She has established that lncRNAs are functional components of important cancer pathways, such as p53’s, and has demonstrated the role of lncRNAs in regulating the expression and stability of the cancer genome. She has published numerous articles in high impact journals like Cell, Nature, Mol Cell and Nature Communications quoted more than 11000 times, and has been invited to give more tan 70 talks at conferences, seminars and international workshops (EMBL, FEBS, EMBL, AACR, FEBS, Karolinska Inst., BRIC Copenhague, Marie Curie Inst, etc.).
Dr. Huarte is a member of the scientific advisory boards of GENCODE and Worldwide Cancer Research and collaborates as external reviewer for international agencies and high tier journals such as Nature, Cell and Science. She holds an active network of collaborators, including the participants of the European RNA training network Marie Curie ITN and IDIFFER excellence network.
Maite Huarte has received the Ser Navarra 2018 Research award, and numerous highly competitive national and international grants, including the first position nation-wide in the Ramon y Cajal Spanish Research Contracts, the Worldwide Cancer Research, and the prestigious ERC Starting and ERC Consolidator Grants.